For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Flamel Ireland Limited

USPTO Granted Patents = 59

% Expired Patents = 1.7

CIPO Patents = 5

EPO Patents = 9

Trademarks = 14

Forward Citations = 1,080

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Jean-François Dubuisson (39 out of 40 patents)

Claire Mégret (39 out of 39 patents)

Hervé Guillard (39 out of 39 patents)

4. Jordan Dubow (14 out of 14 patents)

5. Julien Grassot (10 out of 10 patents)

6. Jordan Dubow (10 out of 10 patents)

7. Cendrine Grangeon (8 out of 8 patents)

8. Catherine Castan (5 out of 15 patents)

9. Heather Kruchowski (4 out of 4 patents)

10. Jenny Reid (4 out of 4 patents)

11. William J Schaefer (4 out of 6 patents)

12. Florence Guimberteau (3 out of 24 patents)

13. Gauthier Pouliquen (3 out of 8 patents)

14. Alain Constancis (3 out of 10 patents)

15. Rémi Meyrueix (3 out of 10 patents)

Core Competencies:

Gamma-Hydroxybutyrate

Modified Release

Pharmacokinetics

Nightly Dose Packet

Controlled-Release

Floating Pharmaceutical

Oral Medicinal Product

Cysteine Composition

59 patents: Sort by Forward Citations

1. 12728110 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2026-09-08),

2. D1141397 - NIGHTLY DOSE PACKET STORAGE SYSTEM (2026-08-18),

3. D1122750 - Nightly dose packet storage set (2026-04-21),

4. 12551457 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2026-02-17),

5. D1102889 - Nightly dose packet storage set (2025-11-25),

6. 12478604 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-11-25),

7. 12303478 - Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state (2025-05-20),

8. 12295926 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-05-13),

9. 12263151 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-04-01),

10. 12263150 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-04-01),

11. 12257223 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-03-25),

12. 12239625 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-03-04),

13. 12226389 - Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics (2025-02-18),

14. 12226388 - Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics (2025-02-18),

15. 12226377 - Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state (2025-02-18),

Company Overview

Flamel Ireland Limited, based in Dublin, specializes in the development and manufacturing of innovative pharmaceutical formulations. The company focuses on advanced drug delivery systems, particularly in the areas of gamma-hydroxybutyrate and controlled-release technologies. Their expertise encompasses pharmacokinetics and the creation of oral medicinal products, including nightly dose packets and floating pharmaceuticals. Flamel is committed to enhancing therapeutic efficacy through its proprietary formulations and technologies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

59 Patents

#34 in Dublin

#60 in Ireland

#12,232 in the World

Dublin, Ireland

Flamel Ireland Limited

Forward Citations = 1,080

31 inventors:

Jean-François Dubuisson (39 out of 40 patents)

Claire Mégret (39 out of 39 patents)

Hervé Guillard (39 out of 39 patents)

4. Jordan Dubow (14 out of 14 patents)

5. Julien Grassot (10 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Flamel Ireland Limited. Retrieved from https://idiyas.com/company/flamel-ireland

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…